DOP03: Unfermented β-fructan fibres can induce gut inflammation and tumorigenesis in select Inflammatory Bowel Disease patients mediated by gut microbiotaECCO’23 Copenhagen 2023
DOP04: Single cell RNA sequencing reveals a potential role for IFNγ in priming circulating monocytes for intestinal inflammatory function in Crohn’s Disease.ECCO’23 Copenhagen 2023
DOP05: Single-cell RNAseq temporal analysis of ulcerative colitis patients undergoing tofacitinib treatment reveals a shift in myeloid cells towards pro-inflammatory phenotypes in refractory patientsECCO’23 Copenhagen 2023
DOP06: Deep characterization of IL-23 pathway in different gut segments and associated plasma biomarkers in inflammatory bowel diseaseECCO’23 Copenhagen 2023
DOP07: Targeting the canonical WNT signalling pathway as a potential novel therapy in Crohn´s associated fibrosisECCO’23 Copenhagen 2023
DOP08: Cellular and molecular interaction of MAIT in mucosal tissue and their role in inflammatory bowel diseaseECCO’23 Copenhagen 2023
DOP09: Eosinophils exert a pro-inflammatory role in a chronic DSS colitis model without an impact on fibrosisECCO’23 Copenhagen 2023
DOP10: Early intestinal resection in Crohn’s Disease is not associated with severe long-term disease courseECCO’23 Copenhagen 2023
DOP11: A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohortsECCO’23 Copenhagen 2023
DOP12: Validation of radiomics features on MR enterography characterizing inflammation and fibrosis in stricturing Crohn’s diseaseECCO’23 Copenhagen 2023
DOP13: Plasma metabolite fingerprint could discriminate inflammatory bowel disease patients from healthy subjectsECCO’23 Copenhagen 2023
DOP14: Identification and validation of a lipidomic signature as a novel diagnostic biomarker of paediatric Inflammatory Bowel DiseaseECCO’23 Copenhagen 2023
DOP15: Intestinal ultrasound correlates with colonoscopy and biomarkers, and can be used in a tight monitoring approach to assess response to therapy in Crohn's disease: a multicentre prospective studyECCO’23 Copenhagen 2023
DOP16: Anti-integrin ⍺vβ6 autoantibodies predate Ulcerative Colitis diagnosis by up to 10 years and are associated with adverse disease-related outcomesECCO’23 Copenhagen 2023
DOP17: HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry.ECCO’23 Copenhagen 2023
DOP18: Brain structural correlates of fatigue in active and quiescent Crohn’s DiseaseECCO’23 Copenhagen 2023
DOP19: Incidence and initial disease presentation of inflammatory bowel diseases in Denmark: findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)ECCO’23 Copenhagen 2023